149 related articles for article (PubMed ID: 3004906)
1. Dopamine inhibits prolactin release when cyclic adenosine 3',5'-monophosphate levels are elevated.
Delbeke D; Scammell JG; Martinez-Campos A; Dannies PS
Endocrinology; 1986 Apr; 118(4):1271-7. PubMed ID: 3004906
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of the adenosine 3',5'-monophosphate and the Ca2+ messenger systems together reverse dopaminergic inhibition of prolactin release.
Delbeke D; Dannies PS
Endocrinology; 1985 Aug; 117(2):439-46. PubMed ID: 2990850
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin inhibits basal and thyrotropin-releasing hormone-induced release of prolactin from anterior pituitary cells: evidence for a selective action exerted proximal to secretagogue-induced increases in cytosolic Ca2+.
Shah GV; Wang W; Grosvenor CE; Crowley WR
Endocrinology; 1990 Aug; 127(2):621-8. PubMed ID: 2115431
[TBL] [Abstract][Full Text] [Related]
4. Biphasic action of forskolin on growth hormone and prolactin secretion by rat anterior pituitary cells in vitro.
Szabo M; Staib NE; Collins BJ; Cuttler L
Endocrinology; 1990 Oct; 127(4):1811-7. PubMed ID: 1698147
[TBL] [Abstract][Full Text] [Related]
5. Effect of dopamine withdrawal on activation of adenylate cyclase and phospholipase C in enriched lactotrophs.
Martinez de la Escalera G; Weiner RI
Endocrinology; 1988 Sep; 123(3):1682-7. PubMed ID: 2456918
[TBL] [Abstract][Full Text] [Related]
6. Mechanism(s) by which the transient removal of dopamine regulation potentiates the prolactin-releasing action of thyrotropin-releasing hormone.
Martinez de la Escalera G; Weiner RI
Neuroendocrinology; 1988 Mar; 47(3):186-93. PubMed ID: 3129665
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C regulation of prolactin gene expression in lactotroph cells: involvement in dopamine inhibition.
Chuang TT; Caccavelli L; Kordon C; Enjalbert A
Endocrinology; 1993 Feb; 132(2):832-8. PubMed ID: 7678802
[TBL] [Abstract][Full Text] [Related]
9. Dopamine and somatostatin inhibit forskolin-stimulated prolactin and growth hormone secretion but not stimulated cyclic AMP levels in sheep anterior pituitary cell cultures.
Ray KP; Gomm JJ; Law GJ; Sigournay C; Wallis M
Mol Cell Endocrinol; 1986 May; 45(2-3):175-82. PubMed ID: 2872092
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin inhibits prolactin secretion by multiple mechanisms involving a site of action distal to increased cyclic adenosine 3',5'-monophosphate and elevated cytosolic Ca2+ in rat lactotrophs.
Bjøro T; Ostberg BC; Sand O; Torjesen PA; Penman E; Gordeladze JO; Iversen JG; Gautvik KM; Haug E
Acta Physiol Scand; 1988 Jul; 133(3):271-82. PubMed ID: 2906508
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin decreases thyrotropin-releasing hormone-stimulated prolactin release through a mechanism that involves inhibition of inositol phosphate production.
Judd AM; Kubota T; Kuan SI; Jarvis WD; Spangelo BL; Macleod RM
Endocrinology; 1990 Jul; 127(1):191-9. PubMed ID: 2163310
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of the inhibitory action of dopamine and somatostatin on prolactin secretion from human lactotrophs in culture.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1985 Mar; 60(3):599-606. PubMed ID: 2579087
[TBL] [Abstract][Full Text] [Related]
13. Dependence of electrical activity and calcium influx-controlled prolactin release on adenylyl cyclase signaling pathway in pituitary lactotrophs.
Gonzalez-Iglesias AE; Jiang Y; Tomić M; Kretschmannova K; Andric SA; Zemkova H; Stojilkovic SS
Mol Endocrinol; 2006 Sep; 20(9):2231-46. PubMed ID: 16645040
[TBL] [Abstract][Full Text] [Related]
14. Comparison of patterns of prolactin release in GH4C1 cells and primary pituitary cultures.
Delbeke D; Kojima I; Dannies PS
Mol Cell Endocrinol; 1985 Nov; 43(1):15-22. PubMed ID: 3934015
[TBL] [Abstract][Full Text] [Related]
15. Difference in calcium requirements for forskolin-induced release of prolactin from normal pituitary cells and GH4C1 cells in culture.
Delbeke D; Scammell JG; Dannies PS
Endocrinology; 1984 Apr; 114(4):1433-40. PubMed ID: 6323146
[TBL] [Abstract][Full Text] [Related]
16. Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells.
Hofland LJ; van Koetsveld PM; Wouters N; Waaijers M; Reubi JC; Lamberts SW
Endocrinology; 1992 Aug; 131(2):571-7. PubMed ID: 1322274
[TBL] [Abstract][Full Text] [Related]
17. Adenosine 3',5'-monophosphate (cAMP) and calcium-calmodulin interrelation in the control of prolactin secretion: evidence for dopamine inhibition of cAMP accumulation and prolactin release after calcium mobilization.
Schettini G; Cronin MJ; MacLeod RM
Endocrinology; 1983 May; 112(5):1801-7. PubMed ID: 6299710
[TBL] [Abstract][Full Text] [Related]
18. Synergistic stimulation of prolactin release by phorbol ester, A23187 and forskolin.
Delbeke D; Kojima I; Dannies PS; Rasmussen H
Biochem Biophys Res Commun; 1984 Sep; 123(2):735-41. PubMed ID: 6091639
[TBL] [Abstract][Full Text] [Related]
19. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
Christian HC; Chapman LP; Morris JF
J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
[TBL] [Abstract][Full Text] [Related]
20. Low concentrations of dopamine increase cytosolic calcium in lactotrophs.
Burris TP; Freeman ME
Endocrinology; 1993 Jul; 133(1):63-8. PubMed ID: 8391429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
